A Nature Biomedical Engineering study described an “egg cell-inspired” biomaterial that shields insulin-producing islet cells after transplantation in diabetic mice. Researchers encapsulated donor rat islet cells in material mimicking the zona pellucida coating and reported protection from immune attack alongside blood glucose lowering for 100 days. The approach aims to reduce the need for broad immunosuppression by providing localized immune shielding while allowing nutrient and insulin transport. The work positions the coating concept as an alternative to encapsulation strategies that often struggle with permeability-thickness tradeoffs. Independent commentary in the report emphasized that maintaining cell viability in vivo is a significant milestone, while also implying that the coating must balance robustness with functional exchange. For biotech, the interest will center on manufacturability and scaling of the encapsulation process and whether the immune-protective effect holds in models closer to human immune complexity.